2
M. Tugrak et al.
J Enzyme Inhib Med Chem, Early Online: 1–6
OH
Scheme 1. Synthesis of MT1.
O
H
EtOH
HO
+
NaOH
10%
O
O
MT1
Discover Microwave Synthesis Systems (CEM Corporation, 126.8, 126.0, 124.3, 121.6, 116.9, 61.3, 54.8, 52.5, 45.8 and 32.5;
Mass spectrum: 349.19 (M+ + 1); HRMS (ESI-MS) Calcd:
349.1916 for C22H25N2O2 [M+H+], found: 349.1902.
Matthews, NC; 908010).
Synthesis of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-
1-one (MT1)
2-(4-Hydroxy-3-(morpholinomethyl)benzylidene)-2,3-
dihydroinden-1-one (MT9)
A solution of the 4-hydroxybenzaldehyde (0.02 mol) in ethanol
1
(6 ml) was added into a stirred solution of 1-indanone (0.02 mol) Yield: 11.3%. m.p.: 171–174 ꢀC. H-NMR (CDCl3) ꢀ 2.62 (4H,
in aqueous solution of sodium hydroxide (10 ml, 10%). Stirring bs, CH2-morpholine), 3.79 (6H, s, CH2-morpholine, CH2–N),
was maintained at room temperature overnight. The reaction 4.00 (2H, s, indeno H-3), 6.91 (1H, d, phenyl H-5,
mixture was then poured onto water (100 ml) and neutralized with J ¼ 8.4 Hz),7.31 (1H, s, phenyl H-2), 7.41 (1H, t, indeno H-6,
hydrochloric acid (10%, w/v). The precipitated solid product J ¼ 7.3 Hz), 7.54–7.62 (4H, m, ¼CH–, indeno H-4, H-5, phenyl
was filtered, washed with water, and crystallized from water– H-6), 7.89 (1H, d, indeno H-7, J ¼ 7.7 Hz); 13C-NMR 194.6,
ethanol22,29 (Scheme 1).
159.8, 149.6, 138.5, 134.5, 134.2, 132.4, 132.1, 132.0, 127.8,
127.3, 126.3, 124.5, 121.4, 117.2, 66.9, 62.0, 53.1 and 32.7; Mass
spectrum: 336.15 (M+ + 1); HRMS (ESI-MS) Calcd: 336.1600 for
C21H22NO3 [M+H+], found: 336.1590.
General synthesis of Mannich bases (MT8–MT15)
The mixture of the compound MT1 (21 mmol), paraformaldehyde
(25 mmol) and suitable secondary amine (21 mmol) [MT8 (N-
methyl piperazine), MT9 (morpholine), MT10 (piperidine), MT11
(pyrrolidine), MT12 (dimethylamine), MT13 (diethylamine),
2-(4-Hydroxy-3-(piperidin-1-ylmethyl)benzylidene)-2,3-
dihydroinden-1-one (MT10)
1
MT14 (dipropylamine) and MT15 (dibenzylamine)] was heated Yield: 6.1%. m.p.: 163–166 ꢀC. H-NMR (CDCl3) ꢀ 1.66 (10H,
in 15 ml of acetonitrile (120 ꢀC, 200 Watt, 13.8 barr) for 15 min bs, CH2-piperidine), 3.74 (2H, s, CH2–N), 3.99 (2H, s, indeno H-
(MT8, MT10, MT13, MT14 and MT15) or 30 min (MT9, MT11 3), 6.88 (1H, d, phenyl H-5, J ¼ 8.4 Hz), 7.28 (1H, d, phenyl H-2,
and MT12). Reactions were monitored by TLC. When the J ¼ 1.8 Hz), 7.41 (1H, t, indeno H-6, J ¼ 6.8 Hz), 7.54–7.62 (4H,
reaction was stopped, reaction solvent was removed under m, ¼CH–, indeno H-4, H-5, phenyl H-6), 7.89 (1H, d, indeno H-7,
vacuum. The compounds MT8, MT15 and MT10 were purified J ¼ 7.7 Hz); 13C NMR 194.3, 160.4, 149.4, 138.4, 134.3, 134.2,
by crystallization. It was EtOH (MT8 and MT15) or MeOH/ 131.9, 131.5, 131.4, 127.5, 126.5, 126, 124.2, 122.1, 116.9, 62.0,
aseton (MT10). On the other hand, the compounds MT9, MT11, 53.9, 32.5, 25.7 and 23.8; Mass spectrum: 334.18 (M+ + 1);
MT12, MT13 and MT14 were purified by column chromatog- HRMS (ESI-MS) Calcd: 334.1807 for C22H24NO2 [M+H+],
raphy on silica gel (SiO2) using suitable solvent system. It was found: 334.1804.
CHCl3:MeOH (98:2) for MT9, CHCl3:MeOH:NH3 (98:2:2) for
MT11, MT13, MT14 and CHCl3:MeOH:NH3 (90:10:2) for MT12
(Scheme 2).
2-(4-Hydroxy-3-(pyrrolidin-1-ylmethyl)benzylidene)-2,3-
dihydroinden-1-one (MT11)
1
Yield: 22.2%. m.p.: 152–154 ꢀC. H-NMR (CDCl3) ꢀ 1.81–1.86
(4H, m, CH2-pyrrolidine), 2.62 (4H, s, CH2-pyrrolidine), 3.84
2 -(4-Hydroxy-benzylidene)-indan-1-one (MT1)
Yield: 76.3%. Melting point (m.p.): 227–229 ꢀC, 235–236 ꢀC29.
(2H, s, CH2–N), 3.90 (2H, s, indeno H-3), 6.84 (1H, d, phenyl H-
1H-NMR (CD3OD) ꢀ 4.04 (2H, s, indeno H-3), 6.88–6.91 (2H, m,
5, J ¼ 8.4 Hz), 7.24 (1H, s, phenyl H-2), 7.34 (1H, t, indeno H-6,
phenyl H-3, H-5), 7.44–7.50 (2H, m, ¼CH–, indeno H-6), 7.57–
7.69 (4H, m, phenyl H-2, H-6, indeno H-4, H-5), 7.80 (1H, d,
indeno H-7, J ¼ 7.7 Hz), 7.90 (1H, s, phenyl 4-OH); 13C-NMR
195.5, 159.9, 150.5, 137.9, 134.9, 134.7, 133.1, 131.7, 127.5,
126.8, 126.5, 123.6, 115.9 and 32.15; mass spectrum: 235.08
[M ꢁ H]+; HRMS (ESI-MS) Calcd: 235.0759 for C16H11O2
[M ꢁ H]+, found: 235.0758.
J ¼ 6.6 Hz), 7.47–7.54 (4H, m, ¼CH–, indeno H-4, H-5, phenyl
H-6), 7.83 (1H, d, indeno H-7, J ¼ 7.7 Hz); 13C-NMR 194.2,
160.4, 149.4,138.3, 134.2, 134.1, 131.5, 131.4, 131.2, 127.4,
126.3, 126.1, 124.1, 122.9, 116.7, 58.7, 53.4, 32.5 and 23.7; Mass
spectrum: 318.14 (M+ + 1); HRMS (ESI-MS) Calcd: 318.1494 for
C21H20NO2 [M+H+], found: 318.1484.
2-(4-Hydroxy-3-((4-methylpiperazin-1-yl)methyl)
benzylidene)-2,3-dihydroinden-1-one (MT8)
2-(4-Hydroxy-3-(dimethylaminomethyl)-benzylidene)
-2,3-dihydroinden-1-one (MT12)
1
1
Yield: 51%. m.p.: 152–154 ꢀC. H-NMR (CDCl3) ꢀ 2.31 (3H, s, Yield: 7.4%. m.p.: 166–169 ꢀC. H-NMR (CDCl3) ꢀ 2.38 (6H,s,
N–CH3), 2.32–2.60 (8H, m, CH2-piperazin ring), 3.79 (2H, s, 2 ꢂ CH3), 3.74 (2H, s, CH2–N), 4.00 (2H, s, indeno H-3), 6.91
CH2–N), 3.99 (2H, s, indeno H-3), 6.90 (1H, d, phenyl H-5, (1H, d, phenyl H-5, J ¼ 8.4 Hz), 7.30 (1H, s, phenyl H-2), 7.43
J ¼ 8.8 Hz), 7.31 (1H, s, phenyl H-2), 7.41 (1H, t, indeno H-6, (1H, t, indeno H-6, J ¼ 7.0 Hz), 7.54–7.62 (4H, m, ¼CH–, indeno
J ¼ 7.2 Hz), 7.54–7.61 (4H, m, ¼CH–, indeno H-4, H-5, phenyl H-4, H-5, phenyl H-6), 7.89 (1H, d, indeno H-7, J ¼ 7.6 Hz); 13C-
H-6) 7.89 (1H, d, indeno H-7, J ¼ 7.7 Hz); 13C-NMR 194.3, NMR 194.3, 160.3, 149.4, 138.4, 134.2, 131.8, 131.7, 131.6,
159.8, 149.4, 138.3, 134.2, 134.1, 131.9, 131.8, 131.7, 127.5, 127.5, 126.6, 126.1, 124.2, 122.2, 116.9, 62.7, 44.4 and 32.5;